Preparing Your Practice for a Changing Alzheimer’s Treatment Landscape
Encouraging developments in the fight against Alzheimer’s disease (AD) and other dementias are all around us. With new treatments coming to market, such as Leqembi (lecanemab), and a pipeline of 140+ agents in development, providers have increasingly powerful weapons to use against AD — adding to expanding data on the impact of lifestyle interventions. However, time is of the essence for a paradigm shift in brain health to foster earlier detection and intervention. How can providers – especially those on the frontlines in primary care — best adapt to this changing landscape and enhance care for older adults?
This webinar provides expert insights into the changing landscape of cognitive care, the criticality of early detection, and the role modern cognitive assessment tools can play in streamlining testing and triage.
Watch the on-demand webinar
Watch the webinar to learn:
The latest on leveraging drug and lifestyle interventions to optimize outcomes
How AI-enhanced tools help providers efficiently spot cognitive issues early
Strategies for implementing digital cognitive assessments in primary care settings
Hear from an expert panel:
John Showalter, MD
Chief Product Officer, Linus Health
John Showalter, MD is the Chief Product Officer at Linus Health and a dual board-certified primary care physician. He previously spent five years as CPO at Jvion, a leader in clinical AI, and 10 years at health systems, most recently serving as CMIO and CHIO at the University of Mississippi Medical Center, where he also practiced clinically in family medicine.
Alvaro Pascual-Leone, MD, PhD
Chief Medical Officer, Linus Health
Alvaro Pascual-Leone, MD, PhD is the Chief Medical Officer and Co-Founder of Linus Health. He is concurrently a Professor of Neurology at Harvard Medical School, a Senior Scientist at the Hinda and Arthur Marcus Institute for Aging Research, and the Medical Director of the Deanna and Sidney Wolk Center for Memory Health at Hebrew SeniorLife in Boston, MA.